The findings, by a team led by Samir Hanash, M.D., Ph.D., head of the Hutchinson Center’s Molecular Diagnostics Program and member of its Public Health Sciences Division, are published online Sept. 12 ahead of the Sept. 13 print issue of Cancer Cell.
“A major feature of this study was that we were able to replicate findings from mouse models of lung cancer in blood samples from humans with lung cancer both at the time of diagnosis and, importantly, prior to the onset of symptoms and diagnosis,” Hanash said. “Our data showed that the protein markers that were tested showed similar concordance between lung cancer in the mouse and lung cancer in humans. This means that developing a blood test to detect lung cancer is increasingly within reach.”
The blood protein signatures discovered in the future may be used in a blood test to not only screen for lung cancer among high-risk individuals such as current and former smokers, but to aid in diagnosis, distinguishing between various subtypes of the disease, such as small-cell lung cancer and lung adenocarcinoma.
Hanash envisions that such a test could be used together with imaging technologies such as CT screening to monitor people at high risk of developing the disease.
“There is a substantial need for simple, non-invasive means to detect lung cancer. While imaging-based screening to detect lung cancer has shown promise, blood-based diagnostics provide a complementary means for detection, disease classification, and monitoring for cancer progression and regression,” the authors wrote.For the study, the researchers conducted in-depth blood protein analysis of three mouse models of lung adenocarcinoma and a genetically engineered mouse model of small-cell lung cancer. To further refine the results, they compared these lung cancer protein profiles to those from other well-established mouse models of pancreatic, ovarian, colon, prostate and breast cancer, as well as two mouse models of inflammation without the presence of cancer. Several protein signatures emerged that were specific to lung cancer:
• In a model of small-cell lung cancer, the researchers found a distinct blood protein signature that was associated with neuroendocrine development.
To determine whether these protein signatures in mice were relevant to human lung cancer, the researchers analyzed blood samples from 28 smokers who had been newly diagnosed with operable lung cancer and blood samples from 26 other subjects that were obtained up to a year before lung cancer was diagnosed. For comparison purposes they also analyzed blood from a similar number of matched, cancer-free controls.
The researchers found striking similarities between the protein signatures in mice and human. For example, in mice with small-cell lung cancer, they found elevated levels of a neural protein called Robo1. They also found significantly increased levels of this protein in patients with small-cell lung cancer as compared to matched human controls.
“Additional validation studies are in progress to further determine the sensitivity and specificity of the marker panels,” Hanash said.
Collaborators on the study included researchers from Memorial Sloan-Kettering Cancer Center, the National Human Genome Research Institute, Yale University School of Medicine, Stanford University, the University of Texas Southwestern Medical Center, and Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Harvard Medical School.
Funding for the research came from the NCI Mouse Models of Human Cancer Program, the NCI Early Detection Research Network, the Canary Foundation, the Thomas G. Labrecque Foundation, the Uniting Against Lung Cancer Foundation, the Department of Defense Congressionally Directed Lung Cancer Research Program and the Parker B. Francis Fellowship Program of the Francis Family Foundation.
Note for media only: To obtain a copy of the embargoed Cancer Cell paper, “Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models,” please contact Mary Beth O’Leary in the journal’s press office at firstname.lastname@example.org or 617-397-2802. To arrange an interview with Hanash, please contact Kristen Woodward in media relations at the Hutchinson Center at email@example.com or 206-667-5095.
At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org.
Kristen Woodward | Newswise Science News
Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory
How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
24.03.2017 | Materials Sciences
24.03.2017 | Physics and Astronomy
24.03.2017 | Physics and Astronomy